• FY26 underlying EBITDA expected to be approximately $135m, at top end of guidance
• Continued very strong occupancy across mature homes, averaging 95.9% in Q3 FY26
• Government funding for accommodation supplement broadly in line with Regis expectations

Regis Healthcare Limited (ASX:REG) expects to deliver an underlying EBITDA result of approximately $135m for FY26, which is at the top end of guidance. Regis' operating performance in Q3 FY26 reflected sustained high occupancy, continued momentum in refundable accommodation deposit (RAD) inflows and solid cash generation. Occupancy levels remained at historically high levels, with average occupancy in mature homes of 95.9% in Q3 FY26 compared with 95.5% in the prior corresponding period. Occupancy performance continues to benefit from targeted sales initiatives, improved hospital discharge pathways and an increasing shortage of available beds in the market. Regis Oxley, acquired as part of the Rockpool acquisition in September 2025, reached full occupancy in March 2026, approximately twelve months after opening. Regis generated net RAD cash inflows of $44.5m in Q3 FY26, taking total net RAD cash inflows for YTD March FY26 to $223m. The paid-up RAD balance was approximately $2.3b as at 31 March 2026. Net RAD cash inflows were supported by recent acquisitions, including Rockpool and OC Health, room pricing adjustments and an increase in the proportion of residents paying RADs. Regis has also implemented a structured cost-savings program aimed at creating a more agile and efficient operating model, while maintaining care quality and frontline capability. The company continues to actively recycle capital to improve the quality, sustainability and earnings profile of the portfolio through a disciplined strategy of quality acquisitions and greenfield developments in attractive catchments, together with the divestment of non-core or lower-returning assets.

FY26 underlying EBITDA expected to be approximately $135m, at the top end of guidance.